Highlight: remodelling the KLK landscape down under

Articles in the same Issue

1. Frontmatter
2. Guest Editorial
3. Highlight: remodelling the KLK landscape down under
4. HIGHLIGHT: 6TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES
5. Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
6. Mechanistic insight from murine models of Netherton syndrome
7. Development of molecules stimulating the activity of KLK3 – an update
8. Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
9. Structural basis for the Zn²⁺ inhibition of the zymogen-like kallikrein-related peptidase 10
10. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
11. Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis
12. A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
13. Therapeutic modulation of tissue kallikrein expression
14. In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
15. A computational analysis of the genetic and transcript diversity at the kallikrein locus
16. Reviews
17. Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
18. The power, pitfalls and potential of the nanodisc system for NMR-based studies
19. Research Articles/Short Communications
20. Cell Biology and Signaling
21. Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine